Funding for this research was provided by:
Deutscher Akademischer Austauschdienst (57141273)
Received: 9 March 2020
Accepted: 11 June 2020
First Online: 22 June 2020
Ethics approval and consent to participate
: Written informed consent was obtained from all participants. This project was reviewed and specifically approved by the Catholic University of Health and Allied Sciences (CUHAS), Ethics Review Board, Mwanza, Tanzania (Research Clearance Certificate No CREC/243/2017) and by the National Institute for Medical Research (Research Clearance Certificate No NIMR/HQ/R.8a/Vol.IX/2679). Participants who were positive by microscopic examination or POC-CCA test cassette for <i>S. mansoni</i> were treated with PZQ using the WHO recommended clinical dosage (40 mg/kg body weight).
: Not applicable.
: The authors declare that they have no competing interests.